Literature DB >> 7572715

Herman Award Lecture, 1995: infection-induced malnutrition--from cholera to cytokines.

W R Beisel1.   

Abstract

Infection-induced malnutrition, the most common form of cytokine-induced malnutrition, results from the actions of proinflammatory cytokines, ie, tumor necrosis factor (TNF) and interleukins 1,6, and 8 (IL-1, IL-6, and IL-8). During acute generalized infections, these cytokines initiate the acute-phase reaction. This reaction is quite stereotyped, and includes fever, malaise, myalgia, headaches, cellular hypermetabolism, and multiple endocrine and enzyme responses. In addition, there is heightened catabolism of muscle proteins and many amino acids; flux of free amino acids into the liver; hepatic synthesis of acute-phase plasma proteins; sequestration of iron and zinc; gluconeo-genesis; insulin resistance; impaired cellular uptake of fatty acids from plasma triglycerides; sizable losses of body nitrogen, potassium, magnesium, phosphate, and zinc; retention of body salt and water; heightened metabolic degradation and/or loss of vitamins; and an activation of the immune system. The pathogenesis of cytokine-induced malnutrition is thus vastly different from the malnutrition caused by uncomplicated starvation. Cytokine-induced malnutrition can have a devastating effect on the immune system and its functions. Although proinflammatory cytokines are found in mucosal fluids, where they contribute to the pathogenesis of inflammatory bowel diseases, it is not known whether cytokines play a role in toxigenic, secretory diarrheas such as cholera, which cause huge losses of body water, electrolytes, and bicarbonate while exhibiting no systemic manifestations of an acute-phase reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572715     DOI: 10.1093/ajcn/62.4.813

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

Review 1.  Cytokines in infectious diseases.

Authors:  S B Boppana
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  [What should be done in weight loss of unknown origin?].

Authors:  A Schwenk
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 3.  Clinical nutrition: 1. Protein-energy malnutrition in the inpatient.

Authors:  L J Hoffer
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

4.  Seasonal variation in weight-for-age in a pediatric emergency room.

Authors:  D A Frank; N Roos; A Meyers; M Napoleone; K Peterson; A Cather; L A Cupples
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

5.  Prognostic factors for persistent diarrhoea managed in a community setting.

Authors:  N Bhandari; R Bahl; M Saxena; S Taneja; M K Bhan
Journal:  Indian J Pediatr       Date:  2000-10       Impact factor: 1.967

Review 6.  Emerging Concepts in Nutrient Needs.

Authors:  Patrick J Stover; Cutberto Garza; Jane Durga; Martha S Field
Journal:  J Nutr       Date:  2020-10-01       Impact factor: 4.798

Review 7.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Rebecca Parish; Kitt Falk Petersen
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

8.  HIV-1 transgene expression in rats induces differential expression of tumor necrosis factor alpha and zinc transporters in the liver and the lung.

Authors:  Pratibha C Joshi; David M Guidot
Journal:  AIDS Res Ther       Date:  2011-10-06       Impact factor: 2.250

9.  Associations among Inflammatory Biomarkers in the Circulating, Plasmatic, Salivary and Intraluminal Anatomical Compartments in Apparently Healthy Preschool Children from the Western Highlands of Guatemala.

Authors:  María José Soto-Méndez; María Eugenia Romero-Abal; Concepción María Aguilera; María Cruz Rico; Noel W Solomons; Klaus Schümann; Angel Gil
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

10.  Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistry.

Authors:  Misaki Wayengera
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.